GU Cancers 2018 | Unmet needs in bladder cancer in the immunotherapy era

Name: Unmet needs in bladder cancer in the immunotherapy era
Uploaded: 2018-02-09T00:00:00.000Z
Duration: 44 s
Description: Despite there now being a variety of promising immunotherapies for bladder cancer, a large proportion of patients don’t respond to these. Speaking from the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Andrea Apolo, MD, of the National Cancer Institute, Bethesda, MD, discusses this issue.

Andrea Apolo • 9 Feb 2018

GU Cancers 2018

Bladder Cancer Genitourinary Cancer

Despite there now being a variety of promising immunotherapies for bladder cancer, a large proportion of patients don’t respond to these. Speaking from the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Andrea Apolo, MD, of the National Cancer Institute, Bethesda, MD, discusses this issue.